NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Enko

Enko

Private
Mystic, ConnecticutFrontier & Industrial Techhttps://www.enko.ag/

Last Round

Series C

Jan 31, 2023

Est. Valuation

$320M

Total Funding Raised

$247M

Company Overview

Enko is an agricultural technology company that develops safe and sustainable small molecule solutions to help farmers protect their crops from pests and diseases.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, Drug Discovery, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

agtechcrop protectionai-driven discoverydna-encoded librariesDELmachine learningherbicide discoveryfungicide discoverydrug discovery for plantshigh-throughput screeningmolecular discoverymode of actionMOAcomputational chemistrysustainable agricultureAI for chemistry

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Enko Comparables

Compare Enko with similar companies based on industry and business-model similarity.

Enko comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Enko Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJan 31, 2023
Series CJul 27, 2022
Series BJun 26, 2020
View all Funding Rounds

Key People

Founding team and executive leadership

Anthony Klemm

Chief Executive Officer

Executive Team

Enko Investors

Notable investors and investment history

Enko investors
InvestorRounds
Bits x BitesSeries B
Eight Roads VenturesSeries C
Germin8 VenturesSeries B, Series C
Anterra CapitalSeries B, Series C, Series A, Seed
Endeavor8Series C
Bill & Melinda Gates FoundationSeries C, Series B
The Bill & Melinda Gates Foundation TrustSeries C, Series B
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2026

    Partnerships with Syngenta and Bayer disclosed in job posting.

  • Jan 21, 2025

    Added ZAGENO Inc., an AgTech/Biotech company, as a customer.

View all signals

Enko Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Enko Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Enko's valuation, stock price, and market status.

Firmographic Details

HeadquartersMystic, Connecticut
Employee Range55
Year Founded2017
Last FundingJan 31, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.